Martin Avenue Pharmacy, Inc.
FDA inspection history in Naperville, Illinois, 2014 to 2017
- 1
- Close-out
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Close-out
- Warning letter
- Form 483
2014: one Form 483; 2015: one warning letter; 2017: one close-out letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2014–17One Form 483, one warning letter and one close-out letter, at Naperville, Illinois.
Cited most
Across all Martin Avenue Pharmacy observations on file
- 21 CFR 211.94(b)Drug product containers and closures2
- 21 CFR 211.111Time limitations on production1
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.166(a)Stability testing1
The complete Martin Avenue Pharmacy file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Naperville, Illinois
One close-out letter, one warning letter and one Form 483 · 2014 to 2017 · 15 observations
Latest: Close-out, Oct 16, 2017 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2017-10-16 | Close-out Close-out letter | Naperville, Illinois | — | $99 |
| 2015-03-18 | Warning letter Warning letter | Naperville, Illinois | — | $99 |
| 2014-07-21 | 483 Form 483 | Naperville, Illinois | 15 | $99 |
Investigators on these documents
FEI number 3003381432 · most recent document Oct 16, 2017
About Martin Avenue Pharmacy, Inc.
How many FDA Form 483s has Martin Avenue Pharmacy, Inc. received?
FDA Intel has 1 Form 483 on file for Martin Avenue Pharmacy, Inc.; the most recent is dated Jul 21, 2014.
When was Martin Avenue Pharmacy, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Martin Avenue Pharmacy, Inc. is a Form 483 dated Jul 21, 2014, for the site in Naperville, Illinois.
What did FDA cite at Martin Avenue Pharmacy, Inc.?
The regulations cited most in the observations on file for Martin Avenue Pharmacy, Inc. are 21 CFR 211.94(b) (Drug product containers and closures), 2 times; 21 CFR 211.111 (Time limitations on production), 1 time; 21 CFR 211.113(b) (Control of microbiological contamination), 1 time.
Has Martin Avenue Pharmacy, Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Martin Avenue Pharmacy, Inc.; the most recent is dated Mar 18, 2015.